EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p‐tau in the earliest Alzheimer's continuum : Evidence across two independent cohorts

Raffaele Cacciaglia, Carles Falcón, Gonzalo Sánchez Benavides, Anna Brugulat-Serrat, Marta Milà Alomà, Marc Suárez Calvet, José Luis Molinuevo, Karine Fauria, Carolina Minguillón, Gwendlyn Kollmorgen, Clara Quijano-Rubio, Kaj Blennow und 8 weitere

Alzheimer's & Dementia · 2025-02 · 21 (2)

DOI: 10.1002/alz.14415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 03.02.2025. Verfasst von Raffaele Cacciaglia und 19 weiteren Autor:innen. Beteiligte Einrichtung: Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Amyloid beta-Peptides, Cognitive Dysfunction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Swedish state under the agreement between the Swedish government and the County Councils, the Avtal om Läkarutbildning och Forskning (ALF)-agreement, the Alzheimer Drug Discovery Foundation (ADDF), USA, the Swedish Alzheimer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Identifying the link between early Alzheimer's disease (AD) pathological changes and neurodegeneration in asymptomatic individuals may lead to the discovery of preventive strategies. We assessed longitudinal brain atrophy and cognitive decline as a function of cerebrospinal fluid (CSF) AD biomarkers in two independent cohorts of cognitively unimpaired (CU) individuals. METHODS We used longitudinal voxel‐based morphometry (VBM) in combination with hippocampal subfield segmentation. Changes in neuroimaging and cognitive variables were inspected using general linear models (GLMs) adjusting by age, sex, apolipoprotein E ( APOE) status, follow‐up time, and years of education. RESULTS In both cohorts, baseline CSF amyloid beta (Aβ) biomarkers significantly predicted medial temporal lobe (MTL) atrophy rates and episodic memory (EM) decline independently of CSF phosphorylated tau (p‐tau). DISCUSSION Our data suggest that soluble Aβ dyshomeostasis triggers MTL longitudinal atrophy and EM decline independently of CSF p‐tau. Our data underscore the need for secondary preventive strategies at the earliest stages of the AD pathological cascade. Highlights We assessed brain atrophy and cognitive decline in asymptomatic individuals. Aβ biomarkers predicted MTL atrophy independently of p‐tau. Our results underscore the importance of undertaking Alzheimer's preclinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAlzheimer DiseaseAmyloid beta-PeptidesCognitive DysfunctionBrainHumansMaleFemaleAgedAtrophyBiomarkersCohort StudiesLongitudinal StudiesMagnetic Resonance ImagingMiddle AgedAged, 80 and overPhosphorylationNeuropsychological TestsMemory, Episodic

Stichwörter der Autor:innen

Amyloid betacerebrospinal fluidmedial temporal lobememoryp‐tau

Substanzen

tau ProteinsAmyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Hospital del Mar Research Institute, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBERBBN), Madrid, Spain.
  • Global Brain Health Institute, San Francisco, California, USA.
  • Northern California Institute for Research and Education, San Francisco, California, USA.

ORCID-Profile: Juan Domingo Gispert

Förderung

  • the Swedish state under the agreement between the Swedish government and the County Councils, the Avtal om Läkarutbildning och Forskning (ALF)-agreement
  • the Alzheimer Drug Discovery Foundation (ADDF), USA
  • the Swedish Alzheimer Foundation
  • the European Union Joint Programme - Neurodegenerative Disease Research
  • European Union's Horizon 2020 Research and Innovation Programme (Grant agreement No. 948677)
  • the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement
  • Hjärnfonden, Sweden
  • the Alzheimer's Association 2021 Zenith Award

Zitieren

APA

Cacciaglia, R., Falcón, C., Benavides, G. S., Brugulat-Serrat, A., Alomà, M. M., Calvet, M. S., Molinuevo, J. L., Fauria, K., Minguillón, C., Kollmorgen, G., Quijano-Rubio, C., Blennow, K., Zetterberg, H., Lorenzini, L., Wink, A. M., Ingala, S., Barkhof, F., Ritchie, C. W., Gispert, J. D., & ALFA study (2025). Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p‐tau in the earliest Alzheimer's continuum : Evidence across two independent cohorts. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14415

Vancouver

Cacciaglia R, Falcón C, Benavides GS, Brugulat-Serrat A, Alomà MM, Calvet MS, et al. Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p‐tau in the earliest Alzheimer's continuum : Evidence across two independent cohorts. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14415

BibTeX
@article{Cacciaglia2025,
  author = {Cacciaglia, Raffaele and Falcón, Carles and Benavides, Gonzalo Sánchez and Brugulat-Serrat, Anna and Alomà, Marta Milà and Calvet, Marc Suárez and Molinuevo, José Luis and Fauria, Karine and Minguillón, Carolina and Kollmorgen, Gwendlyn and Quijano-Rubio, Clara and Blennow, Kaj and Zetterberg, Henrik and Lorenzini, Luigi and Wink, Alle Meije and Ingala, Silvia and Barkhof, Frederik and Ritchie, Craig W and Gispert, Juan Domingo and ALFA study, ALFA study},
  title = {Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p‐tau in the earliest Alzheimer's continuum : Evidence across two independent cohorts},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {2},
  doi = {10.1002/alz.14415}
}
Kostenlos starten →